Related references
Note: Only part of the references are listed.Vanadium and proteins: Uptake, transport, structure, activity and function
Joao Costa Pessoa et al.
COORDINATION CHEMISTRY REVIEWS (2015)
Vanadium compounds in medicine
Joao Costa Pessoa et al.
COORDINATION CHEMISTRY REVIEWS (2015)
The chemistry and biology of vanadium compounds in cancer therapeutics
Efrosini Kioseoglou et al.
COORDINATION CHEMISTRY REVIEWS (2015)
Nonoxido Vanadium(IV) Compounds Involving Dithiocarbazate-Based Tridentate ONS Ligands: Synthesis, Electronic and Molecular Structure, Spectroscopic and Redox Properties
Sanchita Kundu et al.
INORGANIC CHEMISTRY (2015)
Reactivity and Speciation of Anti-Diabetic Vanadium Complexes in Whole Blood and Its Components: The Important Role of Red Blood Cells
Aviva Levina et al.
INORGANIC CHEMISTRY (2015)
Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study
Aviva Levina et al.
INORGANIC CHEMISTRY (2015)
Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems
Daniele Sanna et al.
INORGANIC CHEMISTRY (2015)
Characterization and biotransformation in the plasma and red blood cells of VIVO2+ complexes formed by ceftriaxone
Daniele Sanna et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity: DNA binding and DNA cleavage properties
Isabel Correia et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies
Daniele Sanna et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Metallodrugs in Medicinal Inorganic Chemistry
Katja Dralle Mjos et al.
CHEMICAL REVIEWS (2014)
Structural and redox requirements for the action of anti-diabetic vanadium compounds
Yutaka Yoshikawa et al.
DALTON TRANSACTIONS (2014)
Vanadium Complexes as Prospective Therapeutics: Structural Characterization of a VIV Lysozyme Adduct
Marino F. A. Santos et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2014)
Synthesis and Characterization of VIVO Complexes of Picolinate and Pyrazine Derivatives. Behavior in the Solid State and Aqueous Solution and Biotransformation in the Presence of Blood Plasma Proteins
Tanja Kolesa-Dobravc et al.
INORGANIC CHEMISTRY (2014)
Interaction of Antidiabetic Vanadium Compounds with Hemoglobin and Red Blood Cells and Their Distribution between Plasma and Erythrocytes
Daniele Sanna et al.
INORGANIC CHEMISTRY (2014)
Uptake of potential anti-diabetic VIVO compounds of picolinate ligands by red blood cells
Daniele Sanna et al.
INORGANICA CHIMICA ACTA (2014)
Formation in aqueous solution of a non-oxido V-IV complex with VN6 coordination. Potentiometric, ESI-MS, spectroscopic and computational characterization
Elzbieta Lodyga-Chruscinska et al.
DALTON TRANSACTIONS (2013)
Interaction of Insulin-Enhancing Vanadium Compounds with Human Serum holo-Transferrin
Daniele Sanna et al.
INORGANIC CHEMISTRY (2013)
Formation of New Non-oxido Vanadium(IV) Species in Aqueous Solution and in the Solid State by Tridentate (O, N, O) Ligands and Rationalization of Their EPR Behavior
Daniele Sanna et al.
INORGANIC CHEMISTRY (2013)
VIVO Versus VIV Complex Formation by Tridentate (O, Narom, O) Ligands: Prediction of Geometry, EPR 51V Hyperfine Coupling Constants, and UV-Vis Spectra
Luisa Pisano et al.
INORGANIC CHEMISTRY (2013)
Binding of VIVO2+ to the Fe binding sites of human serum transferrin. A theoretical study
Goncalo C. Justino et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
Interaction of vanadium(IV) with human serum apo-transferrin
Sameena Mehtab et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients
Gail R. Willsky et al.
METALLOMICS (2013)
The binding and transport of alternative metals by transferrin
John B. Vincent et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
VIVO and CuII complexation by ligands based on pyridine nitrogen donors
Daniele Sanna et al.
DALTON TRANSACTIONS (2012)
Evaluation of the binding of oxovanadium(IV) to human serum albumin
Isabel Correia et al.
DALTON TRANSACTIONS (2012)
Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin
Daniele Sanna et al.
DALTON TRANSACTIONS (2012)
Coordinating Properties of Pyrone and Pyridinone Derivatives, Tropolone and Catechol toward the VO2+ Ion: An Experimental and Computational Approach
Daniele Sanna et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2012)
The potentiality of vanadium in medicinal applications
Dieter Rehder
FUTURE MEDICINAL CHEMISTRY (2012)
The effect of the functional, basis set, and solvent in the simulation of the geometry and spectroscopic properties of VIVO2+complexes. chemical and biological applications
Giovanni Micera et al.
INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY (2012)
Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum
Daniele Sanna et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Biotransformation of BMOV in the presence of blood serum proteins
Daniele Sanna et al.
METALLOMICS (2012)
The speciation of vanadium in human serum
Tamas Jakusch et al.
COORDINATION CHEMISTRY REVIEWS (2011)
VO2+ Complexation by Bioligands Showing Keto-Enol Tautomerism: A Potentiometric, Spectroscopic, and Computational Study
Daniele Sanna et al.
INORGANIC CHEMISTRY (2011)
Interaction of VO2+ Ion and Some Insulin-Enhancing Compounds with Immunoglobulin G
Daniele Sanna et al.
INORGANIC CHEMISTRY (2011)
Is the Spin-Orbit Coupling Important in the Prediction of the 51V Hyperfine Coupling Constants of VIVO2+ Species? ORCA Versus Gaussian Performance and Biological Applications
Giovanni Micera et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Titanocene Y and Vanadocene Y: Platinum Resistance-Breaking Cytotoxic and DNA-Targeting Anticancer Drug Candidates
Ralf A. Hilger et al.
Letters in Drug Design & Discovery (2011)
Novel Achiral Aryl-Substituted Vanadocenes: Synthesis and Preliminary Cytotoxicity Studies
Brendan Gleeson et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2010)
Equilibrium Between the Octahedral and Square Pyramidal Form and the Influence of an Axial Ligand on the Molecular Properties of (VO)-O-IV Complexes: A Spectroscopic and DFT Study
Serge Gorelsky et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components
J. Costa Pessoa et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Application of DFT Methods in the Study of VIVO2+-Peptide Interactions
Giovanni Micera et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2010)
Antitumor activity of vanadocene Y and its selenocyanate derivative in xenografted caki-1 tumors in mice
Iduna Fichtner et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2010)
Assessing the Dependence of 51V Az Value on the Aromatic Ring Orientation of VIVO2+ Pyridine Complexes
Giovanni Micera et al.
INORGANIC CHEMISTRY (2009)
On the Transport of Vanadium in Blood Serum
Daniele Sanna et al.
INORGANIC CHEMISTRY (2009)
DNA cleavage activity of VIVO(acac)2 and derivatives
Nataliya Butenko et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Vanadium treatment of type 2 diabetes: A view to the future
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Novel benzyl-substituted vanadocene anticancer drugs
Brendan Gleeson et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2009)
Current state for the development of metallopharmaceutics and anti-diabetic metal complexes
Hiromu Sakurai et al.
CHEMICAL SOCIETY REVIEWS (2008)
Geometries of third-row transition-metal complexes from density-functional theory
Michael Buehl et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state
Bernd Morgenstern et al.
INORGANIC CHEMISTRY (2007)
Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives
P. Manohari Abeysinghe et al.
DALTON TRANSACTIONS (2007)
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes
TC Delgado et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): Transport and biotransformation of insulin-enhancing vanadium pharmaceuticals
BD Liboiron et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Complex formation of vanadium(IV) with 1,3,5-triamino-1,3,5-trideoxy-cis-inositol and related ligands
B Morgenstern et al.
INORGANIC CHEMISTRY (2004)
Density functional theory calculations of the electron paramagnetic resonance parameters for VO2+ complexes
AC Saladino et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2003)
Metal and ligand hyperfine couplings in transition metal complexes: The effect of spin-orbit coupling as studied by coupled perturbed Kohn-Sham theory
F Neese
JOURNAL OF CHEMICAL PHYSICS (2003)
Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes
Y Shechter et al.
COORDINATION CHEMISTRY REVIEWS (2003)
Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity
OJ D'Cruz et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
The systems (VO2+)-O-IV-glutathione and related ligands: a potentiometric and spectroscopic study
JC Pessoa et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2002)
A density functional study of EPR parameters for vanadyl complexes containing schiff base ligands
ML Munzarová et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
Oxovanadium(IV) binding to ligands containing donor sites of biological relevance
E Garribba et al.
INORGANICA CHIMICA ACTA (2001)
Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV)
GR Willsky et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2001)
Vanadocenes as potent anti-proliferative agents disrupting mitotic spindle formation in cancer cells
CS Navara et al.
ANTI-CANCER DRUGS (2001)